{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:03:23Z","timestamp":1793246603273,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajt.2026.07.033","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:48:51Z","timestamp":1787410131000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaccination and safe living strategies for solid organ transplant candidates and recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1961-0477","authenticated-orcid":false,"given":"Deepali","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-3619","authenticated-orcid":false,"given":"Robin","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-5221","authenticated-orcid":false,"given":"Lara","family":"Danziger-Isakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-0059","authenticated-orcid":false,"given":"Victoria G.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-9093","authenticated-orcid":false,"given":"Benjamin","family":"Hanisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4611-0670","authenticated-orcid":false,"given":"Courtney E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4381-0049","authenticated-orcid":false,"given":"Olivia S.","family":"Kates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4576-287X","authenticated-orcid":false,"given":"Hannah H.","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9181-4023","authenticated-orcid":false,"given":"Robert J.","family":"Rolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-2234","authenticated-orcid":false,"given":"Camille N.","family":"Kotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib1","doi-asserted-by":"crossref","first-page":"1040.e11","DOI":"10.1016\/j.cmi.2015.07.014","article-title":"Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe","volume":"21","author":"Perez-Romero","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/ajt.16841","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccination in pediatric solid organ transplant recipients","volume":"22","author":"Qin","year":"2022","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2026.07.033_bib3","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.transproceed.2022.10.023","article-title":"The trajectory of the COVID-19 vaccine antibody titers over time and the association of mycophenolate mofetil in solid organ transplant recipients","volume":"54","author":"Sakai","year":"2022","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3851\/IMP2103","article-title":"Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine","volume":"17","author":"Siegrist","year":"2012","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib5","first-page":"483","article-title":"The influence of selected factors on the immunogenicity of preventive vaccinations against hepatitis A, B and influenza in solid organ transplant recipients undergoing immunosuppressive therapy","volume":"21","author":"Ginda","year":"2022","journal-title":"a review"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1159\/000119742","article-title":"Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial","volume":"28","author":"Keshtkar-Jahromi","year":"2008","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/vaccines13030328","article-title":"Immunogenicity and safety of the bivalent respiratory syncytial virus prefusion F subunit vaccine in immunocompromised or renally impaired adults","volume":"13","author":"Almeida","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib8","doi-asserted-by":"crossref","first-page":"sfag090","DOI":"10.1093\/ckj\/sfag090","article-title":"Impaired humoral and cellular immune responses to recombinant zoster vaccine in kidney transplant recipients treated with belatacept","volume":"19","author":"de Nattes","year":"2026","journal-title":"Clin Kidney J"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.033_bib9","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/TP.0000000000003824","article-title":"Immunogenicity and reactogenicity after SARS-CoV-2 mRNA vaccination in kidney transplant recipients taking belatacept","volume":"105","author":"Ou","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2026.07.033_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1447503","article-title":"Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with belatacept","volume":"15","author":"Pernin","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2026.07.033_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1146841","article-title":"Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections","volume":"14","author":"Egri","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.6822","article-title":"Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review and meta-analysis","volume":"5","author":"Manothummetha","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.healun.2021.11.001","article-title":"SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: a first report","volume":"41","author":"Spinner","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.033_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13804","article-title":"A community divided: posttransplant live vaccine practices among Society of Pediatric Liver Transplantation (SPLIT) centers","volume":"24","author":"Kemme","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.033_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13571","article-title":"Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018","volume":"23","author":"Suresh","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2026.07.033_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37602","article-title":"Safety and immunogenicity of live viral vaccines in a multicenter cohort of pediatric transplant recipients","volume":"6","author":"Feldman","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/jamapediatrics.2024.6778","article-title":"Postvaccination immunogenicity among pediatric solid organ transplant recipients","volume":"179","author":"Feldman","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.ajt.2023.06.008","article-title":"Safety and immunogenicity of the live-attenuated varicella vaccine in pediatric solid organ transplant recipients: a systematic review and meta-analysis","volume":"23","author":"Piche-Renaud","year":"2023","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.033_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw855","article-title":"Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial","volume":"64","author":"Cordero","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/ajt.12987","article-title":"High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients","volume":"15","author":"Leung","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2026.07.033_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2015.04.011","article-title":"Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation","volume":"68","author":"Moal","year":"2015","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13247","article-title":"Durability of the hepatitis B vaccination in pediatric renal transplant recipients","volume":"32","author":"Miller-Handley","year":"2018","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2026.07.033_bib23","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/ajt.17055","article-title":"Effect of influenza vaccination in solid organ transplant recipients: a nationwide population-based cohort study","volume":"22","author":"Harboe","year":"2022","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib24","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/petr.12419","article-title":"Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients","volume":"19","author":"GiaQuinta","year":"2015","journal-title":"Pediatr Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.033_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/jiz471","article-title":"Cell-mediated immune responses after influenza vaccination of solid organ transplant recipients: secondary outcomes analyses of a randomized controlled trial","volume":"221","author":"L\u2019Huillier","year":"2020","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.033_bib28","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/j.1600-6143.2011.03743.x","article-title":"Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients","volume":"11","author":"Schaffer","year":"2011","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.033_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/tid.12006","article-title":"Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients","volume":"14","author":"Fairhead","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.033_bib30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1600-6143.2011.03604.x","article-title":"De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients","volume":"11","author":"Katerinis","year":"2011","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/TP.0000000000000861","article-title":"Randomized controlled trial of adjuvanted versus nonadjuvanted influenza vaccine in kidney transplant recipients","volume":"100","author":"Kumar","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/cid\/ciad477","article-title":"Immunogenicity of high-dose versus mf59-adjuvanted versus standard influenza vaccine in solid organ transplant recipients: the Swiss\/Spanish trial in solid organ transplantation on prevention of influenza (STOP-FLU Trial)","volume":"78","author":"Mombelli","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.033_bib33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.healun.2018.03.001","article-title":"Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis","volume":"37","author":"Mulley","year":"2018","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ndt\/gfr278","article-title":"Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(\u00ae)) in renal transplant recipients","volume":"27","author":"Brakemeier","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009264","article-title":"Effect of the adjuvanted (AS03) A\/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series","volume":"6","author":"Cohet","year":"2016","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.033_bib36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40264-017-0532-3","article-title":"Adjuvanted (AS03) A\/H1N1 2009 pandemic influenza vaccines and solid organ transplant rejection: systematic signal evaluation and lessons learnt","volume":"40","author":"Dos Santos","year":"2017","journal-title":"Drug Saf"},{"issue":"34","key":"10.1016\/j.ajt.2026.07.033_bib37","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1016\/j.vaccine.2011.06.010","article-title":"Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone \u00ae ) administered by intradermal and intramuscular route in healthy adults","volume":"29","author":"Frenck","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.033_bib38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A 5-Year Prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ajt.2026.07.033_bib39","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1600-6143.2011.03753.x","article-title":"Influenza vaccination in the organ transplant recipient: review and summary recommendations","volume":"11","author":"Kumar","year":"2011","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib40","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/ajt.16933","article-title":"A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients","volume":"22","author":"Karaba","year":"2022","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/M21-3480","article-title":"Neutralization of SARS-CoV-2 variants in transplant recipients after two and three doses of mRNA-1273 vaccine: secondary analysis of a randomized trial","volume":"175","author":"Kumar","year":"2022","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.033_bib42","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1681\/ASN.2021070966","article-title":"B and T cell responses after a third dose of SARS-CoV-2 vaccine in kidney transplant recipients","volume":"32","author":"Schrezenmeier","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib43","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/infdis\/jiad511","article-title":"Prospective assessment of humoral and cellular immune responses to a third COVID-19 mRNA vaccine dose among immunocompromised individuals","volume":"229","author":"Haidar","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajt.2026.07.033_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1039245","article-title":"Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls","volume":"13","author":"Balsby","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib45","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1093\/infdis\/jiae140","article-title":"Safety and immunogenicity of the mRNA-1273 coronavirus disease 2019 vaccine in solid organ transplant recipients","volume":"230","author":"Figueroa","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajt.2026.07.033_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.033_bib47","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/ndt\/gfac174","article-title":"Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis","volume":"37","author":"Verleye","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13308","article-title":"Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: post-hoc analysis of a Japanese national prospective study","volume":"98","author":"Yoshikawa","year":"2023","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib49","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/TP.0000000000004386","article-title":"Humoral and cellular response of transplant recipients to a third dose of mRNA SARS-CoV-2 Vaccine: a systematic review and meta-analysis","volume":"107","author":"Bailey","year":"2023","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.033_bib50","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1111\/ajt.16768","article-title":"Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients","volume":"21","author":"Herrera","year":"2021","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.idc.2023.03.002","article-title":"COVID-19 prevention in solid organ transplant recipients: current state of the evidence","volume":"37","author":"Vafea","year":"2023","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib52","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/infdis\/jiac118","article-title":"mRNA vaccine effectiveness against coronavirus disease 2019 hospitalization among solid organ transplant recipients","volume":"226","author":"Kwon","year":"2022","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1473-3099(22)00650-8","article-title":"Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial","volume":"23","author":"Kho","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.033_bib54","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1093\/cid\/ciaf107","article-title":"Replacing mycophenolate mofetil by everolimus in kidney transplant recipients to increase vaccine immunogenicity: results of a randomized controlled trial","volume":"81","author":"Messchendorp","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajt.2026.07.033_bib55","unstructured":"Respiratory syncytial virus (RSV) vaccines: Canadian Immunization Guide. Public Health Agency of Canada. Accessed July 15, 2026. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/respiratory-syncytial-virus.html."},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cmi.2025.09.013","article-title":"Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study","volume":"32","author":"Hall","year":"2026","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib57","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.2024.25395","article-title":"Antibody response to respiratory syncytial virus vaccination in immunocompromised persons","volume":"333","author":"Karaba","year":"2025","journal-title":"JAMA"},{"issue":"10462","key":"10.1016\/j.ajt.2026.07.033_bib58","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(24)01738-0","article-title":"Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis","volume":"404","author":"Payne","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib59","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8322","article-title":"Effectiveness and safety of respiratory syncytial virus vaccine for US adults aged 60 years or older","volume":"8","author":"Fry","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.033_bib60","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/infdis\/jiac192","article-title":"Waning immunity against respiratory syncytial virus during the coronavirus disease 2019 pandemic","volume":"226","author":"Reicherz","year":"2022","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib61","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1093\/infdis\/jiaf101","article-title":"Recovery of antibody immunity after a resurgence of respiratory syncytial virus infections","volume":"231","author":"Reicherz","year":"2025","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.ajt.2026.07.033_bib62","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/jama.2025.15896","article-title":"RSV vaccine effectiveness against hospitalization among US adults aged 60 years or older during 2 seasons","volume":"334","author":"Surie","year":"2025","journal-title":"JAMA"},{"issue":"34","key":"10.1016\/j.ajt.2026.07.033_bib63","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices - United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-6143.2006.01618.x","article-title":"Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients","volume":"7","author":"Lin","year":"2007","journal-title":"Am J Transplant"},{"issue":"13","key":"10.1016\/j.ajt.2026.07.033_bib65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal hepatitis B vaccination in adults aged 19-59 Years: updated recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"15","key":"10.1016\/j.ajt.2026.07.033_bib66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.033_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2136912","volume":"18","author":"Girndt","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib68","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/ndt\/gfac039","article-title":"A real world comparison of HepB (Engerix-B\u00ae) and HepB-CpG (Heplisav-B\u00ae) vaccine seroprotection in patients receiving maintenance dialysis","volume":"38","author":"Manley","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"31","key":"10.1016\/j.ajt.2026.07.033_bib69","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1016\/j.vaccine.2023.06.041","article-title":"Vaccination with HepB-CpG vaccine in individuals undergoing immune suppressive drug therapy","volume":"41","author":"Perrillo","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib70","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2025.2541873","article-title":"Optimizing hepatitis B vaccination in chronic kidney disease: a comprehensive scoping review of strategies across CKD stages, dialysis, and transplant populations","volume":"47","author":"Chancharoenthana","year":"2025","journal-title":"Ren Fail"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.033_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15464","article-title":"Hepatitis B vaccine compliance, serologic response, and durability in adult thoracic organ transplant recipients","volume":"38","author":"Chiu","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ajt.2026.07.033_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126705","article-title":"Optimizing hepatitis B virus seroprotection in thoracic organ transplantation: the role of HepB-CpG (Heplisav-B) vaccination schedule","volume":"47","author":"Chiu","year":"2025","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib73","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/jlts.2001.23069","article-title":"Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease","volume":"7","author":"Arslan","year":"2001","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00042737-200104000-00010","article-title":"Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates","volume":"13","author":"Engler","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib75","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1872-034X.2012.01102.x","article-title":"Immunogenicity of different hepatitis B virus vaccination schedules in liver transplant recipients","volume":"43","author":"Feng","year":"2013","journal-title":"Hepatol Res"},{"issue":"RR-16","key":"10.1016\/j.ajt.2026.07.033_bib76","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.033_bib77","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM198408233110803","article-title":"Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy","volume":"311","author":"Stevens","year":"1984","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1016\/j.ajt.2026.07.033_bib78","first-page":"1590","article-title":"Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial","volume":"85","author":"Carey","year":"1990","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.033_bib79","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5144\/0256-4947.2013.591","article-title":"Isolated hepatitis B core antibody positive among vaccinated cohort in Malaysia","volume":"33","author":"Hudu","year":"2013","journal-title":"Ann Saudi Med"},{"issue":"9203","key":"10.1016\/j.ajt.2026.07.033_bib80","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ajt.2026.07.033_bib81","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/374784","article-title":"Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients","volume":"187","author":"Kumar","year":"2003","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.033_bib82","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1086\/591537","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients","volume":"47","author":"Kumar","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib83","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1600-6143.2007.01668.x","article-title":"Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial","volume":"7","author":"Kumar","year":"2007","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.033_bib86","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/TP.0b013e318249b13d","article-title":"Anogenital malignancies in women after renal transplantation over 40 years in a single center","volume":"93","author":"Meeuwis","year":"2012","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib87","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/bjs.7218","article-title":"Human papillomavirus infection and anal dysplasia in renal transplant recipients","volume":"97","author":"Patel","year":"2010","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.033_bib88","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.12472","article-title":"HPV-related cancers after solid organ transplantation in the United States","volume":"13","author":"Madeleine","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/ajt.15056","article-title":"Risk of genital warts in renal transplant recipients-a registry-based, prospective cohort study","volume":"19","author":"Larsen","year":"2019","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.033_bib90","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1086\/374716","article-title":"Smallpox vaccination and the patient with an organ transplant","volume":"36","author":"Dropulic","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajt.2026.07.033_bib91","series-title":"CDC yellow book 2020: health information for international travel","year":"2019"},{"issue":"26","key":"10.1016\/j.ajt.2026.07.033_bib92","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of postmarketing surveillance data from Japan and the United States. The VAERS Working Group","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.ajt.2026.07.033_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1452916","article-title":"Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant","volume":"14","author":"Miyaji","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib94","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14476","article-title":"Immunogenicity of a quadrivalent human papillomavirus vaccine in pediatric kidney and liver transplant recipients","volume":"27","author":"Kitano","year":"2023","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib95","first-page":"776","article-title":"Immunogenicity of human papillomavirus recombinant vaccine in children with CKD. Clin J Am Soc Nephrol","volume":"11","author":"Nelson","year":"2016"},{"issue":"22","key":"10.1016\/j.ajt.2026.07.033_bib96","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2016.17615","article-title":"Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women","volume":"316","author":"Iversen","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12519-008-0047-1","article-title":"Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs","volume":"4","author":"Danerseau","year":"2008","journal-title":"World J Pediatr"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib99","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1097\/TP.0000000000005547","article-title":"Seroprevalence and incidence of measles, mumps, and rubella in adult solid organ transplant recipients in the United States: a large database analysis","volume":"110","author":"Chiu","year":"2026","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib102","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ajt.15101","article-title":"Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation","volume":"19","author":"Pittet","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2026.07.033_bib100","article-title":"Red Book: 2024\u20132027 Report of the Committee on Infectious Diseases, Committee on Infectious Diseases, American Academy of Pediatric","year":"2015"},{"key":"10.1016\/j.ajt.2026.07.033_bib101","first-page":"68","article-title":"Active immunization after receipt of antibody-containing products","volume":"2027","year":"2024","journal-title":"Red Book"},{"key":"10.1016\/j.ajt.2026.07.033_bib104","unstructured":"Updated recommendations on measles postexposure prophylaxis. Public Health Agency of Canada. Accessed July 15, 2026. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-statement-updated-recommendations-measles-postexposure-prophylaxis.html."},{"issue":"7","key":"10.1016\/j.ajt.2026.07.033_bib105","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archderm.142.7.943","article-title":"Varicella infection caused by Oka strain vaccine in a heart transplant recipient","volume":"142","author":"Kraft","year":"2006","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib106","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1600-6143.2012.04273.x","article-title":"Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic","volume":"12","author":"Posfay-Barbe","year":"2012","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2026.07.033_bib107","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/TP.0000000000003621","article-title":"Evaluation of recombinant herpes zoster vaccine for primary immunization of varicella-seronegative transplant recipients","volume":"105","author":"L\u2019Huillier","year":"2021","journal-title":"Transplantation"},{"issue":"22","key":"10.1016\/j.ajt.2026.07.033_bib108","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib109","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/ciz177","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial","volume":"70","author":"Vink","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.033_bib110","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw058","article-title":"Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients","volume":"23","author":"Trubiano","year":"2016","journal-title":"J Travel Med"},{"key":"10.1016\/j.ajt.2026.07.033_bib111","unstructured":"Immunocompromised Travelers. Centers for Disease Control and Prevention. Accessed September 8, 2026. https:\/\/www.cdc.gov\/yellow-book\/hcp\/travelers-with-additional-considerations\/immunocompromised-travelers.html."},{"issue":"9","key":"10.1016\/j.ajt.2026.07.033_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13529","article-title":"Travel medicine, transplant tourism, and the solid organ transplant recipient-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Buchan","year":"2019","journal-title":"Clin Transplant"},{"issue":"36","key":"10.1016\/j.ajt.2026.07.033_bib113","doi-asserted-by":"crossref","first-page":"959","DOI":"10.15585\/mmwr.mm6636a5","article-title":"Updated dosing instructions for immune globulin (human) gamaSTAN S\/D for hepatitis A virus prophylaxis","volume":"66","author":"Nelson","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajt.2026.07.033_bib116","unstructured":"Meningococcal Disease. Centers for Disease Control and Prevention. Accessed September 8, 2026. https:\/\/www.cdc.gov\/yellow-book\/hcp\/travel-associated-infections-diseases\/meningococcal-disease.html."},{"key":"10.1016\/j.ajt.2026.07.033_bib117","unstructured":"Yellow Fever. Centers for Disease Control and Prevention. Accessed September 8, 2026. https:\/\/www.cdc.gov\/yellow-book\/hcp\/travel-associated-infections-diseases\/yellow-fever.html."},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib118","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.TP.0000101435.91619.31","article-title":"Community-acquired West Nile virus infection in solid-organ transplant recipients","volume":"77","author":"Kumar","year":"2004","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib119","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.4294","article-title":"Neuroinvasive West Nile virus infection in immunosuppressed and immunocompetent adults","volume":"7","author":"Mbonde","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2S Suppl 2","key":"10.1016\/j.ajt.2026.07.033_bib120","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/TP.0000000000002011","article-title":"Arboviruses recommendations for solid-organ transplant recipients and donors","volume":"102","author":"Morris","year":"2018","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.033_bib121","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/vbz.2019.2608","article-title":"West Nile virus: an emerging threat in transplant population","volume":"20","author":"Mrzljak","year":"2020","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib122","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14004","article-title":"Neuroinvasive West Nile virus infection in solid organ transplant recipients","volume":"25","author":"Kasule","year":"2023","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.033_bib123","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14400","article-title":"A scoping review of arthropod-borne flavivirus infections in solid organ transplant recipients","volume":"26","author":"Im","year":"2024","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ajt.2026.07.033_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1256149","article-title":"An integrated public health response to an outbreak of Murray Valley encephalitis virus infection during the 2022-2023 mosquito season in Victoria","volume":"11","author":"Braddick","year":"2023","journal-title":"Front Public Health"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib125","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/v16111778","article-title":"Arbovirus in solid organ transplants: a narrative review of the literature","volume":"16","author":"Gajurel","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ajt.2026.07.033_bib126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coviro.2020.05.001","article-title":"Climate change and viral emergence: evidence from Aedes-borne arboviruses","volume":"40","author":"Robert","year":"2020","journal-title":"Curr Opin Virol"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib127","doi-asserted-by":"crossref","first-page":"371","DOI":"10.34172\/hpp.2021.48","article-title":"Tackling the global health threat of arboviruses: an appraisal of the three holistic approaches to health","volume":"11","author":"Tajudeen","year":"2021","journal-title":"Health Promot Perspect"},{"issue":"1665","key":"10.1016\/j.ajt.2026.07.033_bib128","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0561","article-title":"Climate change impacts on West Nile virus transmission in a global context","volume":"370","author":"Paz","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"issue":"RR-16","key":"10.1016\/j.ajt.2026.07.033_bib129","first-page":"1","volume":"51","author":"Boyce","year":"2002","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cmi.2016.12.001","article-title":"A microbiome assessment of medical marijuana","volume":"23","author":"Thompson","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib131","doi-asserted-by":"crossref","first-page":"e4090","DOI":"10.1093\/cid\/ciaa1097","article-title":"Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study","volume":"73","author":"Kates","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib132","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ajt.16840","article-title":"Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic","volume":"22","author":"Heldman","year":"2022","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib133","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.3390\/v13112146","article-title":"Respiratory viruses in solid organ transplant recipients","volume":"13","author":"Bitterman","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib134","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14787210.2022.2013808","article-title":"Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review","volume":"20","author":"Filippidis","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ajt.2026.07.033_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105157","article-title":"Relative efficacy of masks and respirators as source control for viral aerosol shedding from people infected with SARS-CoV-2: a controlled human exhaled breath aerosol experimental study","volume":"104","author":"Lai","year":"2024","journal-title":"EbioMedicine"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.033_bib136","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MOT.0000000000001106","article-title":"Respiratory viral infections including COVID-19 in solid organ transplantation","volume":"28","author":"Lo","year":"2023","journal-title":"Curr Opin Organ Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.033_bib137","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.ajt.2024.03.011","article-title":"Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023","volume":"24","author":"Solera","year":"2024","journal-title":"Am J Transplant"},{"issue":"45","key":"10.1016\/j.ajt.2026.07.033_bib138","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1016\/j.vaccine.2023.09.036","article-title":"Implementation of a vaccination clinic for adult solid organ transplant candidates: a single-center experience","volume":"41","author":"Harboe","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ajt.2026.07.033_bib139","unstructured":"Measles Cases and Outbreaks. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/measles\/data-research\/index.html. Accessed 10 Sep 2026."},{"key":"10.1016\/j.ajt.2026.07.033_bib140","unstructured":"Pertussis Surveillance and Trends. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/pertussis\/php\/surveillance\/index.html. Accessed 10 Sep 2026."},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib141","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1016\/S2542-5196(23)00046-3","article-title":"Risk of systemic fungal infections after exposure to wildfires: a population-based, retrospective study in California","volume":"7","author":"Mulliken","year":"2023","journal-title":"Lancet Planet Health"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib142","doi-asserted-by":"crossref","first-page":"ofad093","DOI":"10.1093\/ofid\/ofad093","article-title":"Invasive mold infections following Hurricane Harvey-Houston, Texas","volume":"10","author":"Toda","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.033_bib143","doi-asserted-by":"crossref","first-page":"e01414","DOI":"10.1128\/mBio.01414-20","article-title":"Tornadic shear stress induces a transient, calcineurin-dependent hypervirulent phenotype in mucorales molds","volume":"11","author":"Wurster","year":"2020","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.033_bib144","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13807","article-title":"Complications of Cryptosporidium infection after pediatric liver transplantation: diarrhea, rejection, and biliary disease","volume":"24","author":"Fischer","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/20477724.2023.2290379","article-title":"infection in solid organ transplant recipients: a systematic review and meta-analysis","volume":"118","author":"Ahmed","year":"2024","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.ajt.2026.07.033_bib146","unstructured":"How to Make Water Safe in an Emergency. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/water-emergency\/about\/index.html. Accessed 10 Sep 2026."},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib147","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3201\/eid3004.231076","article-title":"Acanthamoeba infection and nasal rinsing, United States, 1994-2022","volume":"30","author":"Haston","year":"2024","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib148","first-page":"669","article-title":"Foodborne illness acquired in the United States-major pathogens, 2019","volume":"31","author":"Scallan Walter","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajt.2026.07.033_bib149","unstructured":"Estimates: Burden of Foodborne Illness in the United States. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/food-safety\/php\/data-research\/foodborne-illness-burden\/. Accessed 10 Sep 2026."},{"issue":"26","key":"10.1016\/j.ajt.2026.07.033_bib150","doi-asserted-by":"crossref","first-page":"584","DOI":"10.15585\/mmwr.mm7326a1","article-title":"Reported incidence of infections caused by pathogens transmitted commonly through food: impact of increased use of culture-independent diagnostic tests - foodborne diseases active surveillance network, 1996-2023","volume":"73","author":"Shah","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib151","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/antibiotics12050880","article-title":"Antibiotic resistance in selected emerging bacterial foodborne pathogens-an issue of concern?","volume":"12","author":"Grudlewska-Buda","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib152","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ajt.16831","article-title":"Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients","volume":"22","author":"van den Bogaart","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2026.07.033_bib153","unstructured":"Food Safety: A Need-to-Know Guide for Those at Risk. United States Department of Agriculture. https:\/\/www.fsis.usda.gov\/sites\/default\/files\/media_file\/2021-04\/at-risk-booklet.pdf. Accessed 10 Sep 2026."},{"issue":"5","key":"10.1016\/j.ajt.2026.07.033_bib154","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/ajt.15725","article-title":"Real-life food-safety behavior and incidence of foodborne infections in solid organ transplant recipients","volume":"20","author":"Lindup","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/tid.12354","article-title":"Strategies for safe living among lung transplant recipients: a single-center survey","volume":"17","author":"Jain","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ajt.2026.07.033_bib156","article-title":"Return to Work and Occupational Infection Risks in Transplant Recipients [abstract]","volume":"15","author":"Avery","year":"2015","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib158","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14527","article-title":"Pet safety guidelines for pediatric transplant recipients","volume":"28","author":"Kilduff","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.033_bib159","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/TP.0000000000004419","article-title":"Balancing the risks and benefits of pet ownership in pediatric transplant recipients","volume":"107","author":"Garcia Sanchez","year":"2023","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.033_bib160","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13949","article-title":"Promoting safe sexual practices and sexual health maintenance in pediatric and young adult solid organ transplant recipients","volume":"25","author":"Ardura","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.ajt.2026.07.033_bib161","article-title":"Recreational and lifestyle infection risks in transplant recipients","volume":"15","author":"Avery","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2026.07.033_bib162","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drugalcdep.2017.09.039","article-title":"Marijuana use is associated with hypersensitivity to multiple allergens in US adults","volume":"182","author":"Min","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.033_bib163","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOT.0b013e3282f56139","article-title":"The debate about marijuana usage in transplant candidates: recent medical evidence on marijuana health effects","volume":"13","author":"Coffman","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.033_bib164","doi-asserted-by":"crossref","first-page":"ofaa503","DOI":"10.1093\/ofid\/ofaa503","article-title":"Opportunities to offer harm reduction to people who inject drugs during infectious disease encounters: narrative review","volume":"7","author":"Peckham","year":"2020","journal-title":"Open Forum Infect Dis"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526026985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526026985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:44:19Z","timestamp":1790196259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526026985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":157,"alternative-id":["S1600613526026985"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.07.033","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination and safe living strategies for solid organ transplant candidates and recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}